AGF U.S. Market Neutral Anti-Beta Fund Rating $12.20 0.00 (0.00%) Closing price 05/22/2026 04:10 PM EasternExtended Trading$12.24 +0.04 (+0.30%) As of 05/22/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort InterestBuy This Stock AGF U.S. Market Neutral Anti-Beta Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BTAL Aggregate RatingModerate Buy 2.57Holdings in BTAL have an aggregate rating of Moderate Buy based on 393 analyst ratings issued in the past year covering 24 companies (13.5% of the portfolio).BTAL Aggregate Price Target$12.20High Prediction$12.20Average Prediction$12.20Low Prediction$12.20Holdings in BTAL have an aggregate price target of $12.20 and a range of $12.20 to $12.20 covering 24 companies (13.5% of the portfolio).BTAL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AGF U.S. Market Neutral Anti-Beta Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BTAL Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings0.73%AKAMAkamai Technologies$147.232.6035 of 5 stars2.41$145.29 -1.3%220.67%MUSAMurphy USA$544.32+0.3%3.3618 of 5 stars2.56$503.71 -7.5%90.64%CSCOCisco Systems$120.414.2281 of 5 stars2.77$118.14 -1.9%26Positive News0.61%FFIVF5$393.633.3681 of 5 stars2.42$353.00 -10.3%120.61%ARWArrow Electronics$217.55+0.1%3.7534 of 5 stars2.67$214.50 -1.4%6Insider Trade0.61%VIRTVirtu Financial$52.460.0%3.358 of 5 stars2.50$48.67 -7.2%80.60%UNHUnitedHealth Group$388.420.0%4.0813 of 5 stars2.74$387.57 -0.2%27Positive NewsAnalyst Forecast0.60%CNCCentene$59.15+0.0%2.2994 of 5 stars2.37$56.94 -3.7%19Analyst Forecast0.59%VRSNVeriSign$310.003.9837 of 5 stars2.60$317.67 2.5%5Positive News0.57%EBAYeBay$115.753.3338 of 5 stars2.36$107.90 -6.8%330.56%CFCF Industries$121.81+0.1%3.0034 of 5 stars2.37$118.47 -2.7%19Analyst Revision0.56%MOHMolina Healthcare$184.080.0%2.2811 of 5 stars2.06$176.00 -4.4%16Positive NewsAnalyst Forecast0.56%ULSUL Solutions$102.87+0.0%3.3267 of 5 stars2.64$101.54 -1.3%11Positive NewsDividend AnnouncementInsider Trade0.54%CBOECboe Global Markets$357.351.8651 of 5 stars2.31$322.60 -9.7%130.53%ELVElevance Health$394.41-0.1%4.3799 of 5 stars2.61$399.32 1.2%23Positive NewsAnalyst Forecast0.53%FCFSFirstCash$227.593.7598 of 5 stars3.17$198.00 -13.0%60.53%RPRXRoyalty Pharma$54.504.0029 of 5 stars3.00$53.71 -1.4%70.52%HRBH&R Block$38.94+0.1%3.9217 of 5 stars2.50$41.00 5.3%4Gap Down0.51%VRNSVaronis Systems$31.003.2227 of 5 stars2.70$41.35 33.4%230.49%OKTAOkta$92.243.9163 of 5 stars2.68$101.86 10.4%41Upcoming EarningsGap Down0.49%OXYOccidental Petroleum$58.82+0.0%3.4339 of 5 stars2.35$62.91 7.0%260.49%WSOWatsco$374.58-0.2%3.2604 of 5 stars2.11$399.83 6.7%9Analyst Revision0.48%THGThe Hanover Insurance Group$195.34+0.1%4.589 of 5 stars2.90$205.86 5.4%10Analyst Upgrade0.48%MPMP Materials$64.42-0.1%3.9538 of 5 stars3.06$80.08 24.3%18Gap Down This page (NYSEARCA:BTAL) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AGF U.S. Market Neutral Anti-Beta Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share AGF U.S. Market Neutral Anti-Beta Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
